Fidelity Investments
CAMP icon

Fidelity Investments’s CAMP4 Therapeutics CAMP Stock Holding History

Fidelity Investments’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4M Sell
4,904,339
-29,093
-0.6% -$125K ﹤0.01% 1862
2026
Q1 		$21.8M Buy
4,933,432
+15,189
+0.3% +$72.1K ﹤0.01% 1754
2025
Q4 		$30.1M Buy
4,918,243
+1,894,809
+63% +$8.06M ﹤0.01% 1630
2025
Q3 		$9.07M Buy
3,023,434
+2,415,488
+397% +$4.47M ﹤0.01% 2037
2025
Q2 		$882K Sell
607,946
-159,001
-21% -$316K ﹤0.01% 2764
2025
Q1 		$3.07M Buy
766,947
+11,922
+2% +$57.7K ﹤0.01% 2319
2024
Q4 		$3.94M Buy
+755,025
New +$6.2M ﹤0.01% 2240

Other funds holding CAMP

JT
Jupiter Topco New York $245B AUM
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Fidelity Investments's CAMP Position: Q2 2026 in Review

Fidelity Investments reduced its CAMP4 Therapeutics (CAMP) stake by 0.59% in Q2 2026, selling an estimated $125K and leaving 4,904,339 shares worth $21.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Fidelity Investments first reported a position in CAMP in Q4 2024 and has held it in 7 quarters since. The position peaked at $30.1M in Q4 2025. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Fidelity Investments held 4,904,339 shares of CAMP4 Therapeutics worth $21.4M as of Q2 2026.
  • Fidelity Investments sold 29,093 CAMP4 Therapeutics shares in Q2 2026, an estimated $125K.
  • CAMP4 Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1862 holding.
  • Fidelity Investments first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Fidelity Investments's CAMP4 Therapeutics position peaked at $30.1M in Q4 2025.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.